Total Funding
49
58
Total FundingSeries C raised
Growth Score
-2 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
73710
Curiox Biosystems is a biotechnology firm that revolutionising the field of suspension cell sample preparation with innovative technologies.
- Donald J. O'Neil: Chief Commercial Officer
- Namyong Kim: Chief Executive Officer (CEO)
About the Company
Curiox is a bioinstrumentation company spun out of the Agency for Science, Technology, and Research (A*STAR) in Singapore. Curiox has become a leader in the development and commercialization of innovative assay platforms based on its expertise in surface chemistry and engineering. Curiox’s vision is to accelerate the progress of life sciences, drug
discovery and diagnostics through the miniaturization and improved automation of bioassays.
